MAP PHARMACEUTICALS, INC. Financing Cash Flow
MAP PHARMACEUTICALS, INC. reported Financing Cash Flow of $330.07 million for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2012-09-30 was $56.38M.
- MAP PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was $683.00K.
- MAP PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was $190.00K.
- MAP PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was -$987.00K, a 102.16% decline year-over-year.
- MAP PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2011 was -$5.15M, a 108.36% decline from fiscal 2010.
- MAP PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2010 was $61.67M, a 133.32% increase from fiscal 2009.
- MAP PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2009 was $26.43M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 96 month | Net Cash Provided by (Used in) Financing Activities 99 month | Net Cash Provided by (Used in) Financing Activities 102 month | Net Cash Provided by (Used in) Financing Activities 105 month | Net Cash Provided by (Used in) Financing Activities 108 month | Net Cash Provided by (Used in) Financing Activities 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $56.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $57.07M derived: sum of 2 quarters · filed 2012-11-06 | $57.26M 10-Q · filed 2012-11-06 | $56.27M derived: sum of 4 quarters · filed 2012-11-06 | $330.07M 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | $683.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $873.00K 10-Q · filed 2012-07-27 | -$114.00K derived: sum of 3 quarters · filed 2012-07-27 | -$2.12M derived: sum of 4 quarters · filed 2012-11-06 | $273.69M 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | $190.00K 10-Q · filed 2012-05-08 | -$797.00K derived: sum of 2 quarters · filed 2012-05-08 | -$2.80M derived: sum of 3 quarters · filed 2012-11-06 | -$3.48M derived: sum of 4 quarters · filed 2012-11-06 | $273.00M 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | -$987.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$2.99M derived: sum of 2 quarters · filed 2012-11-06 | -$3.67M derived: sum of 3 quarters · filed 2012-11-06 | -$5.15M 10-K · filed 2012-03-30 | $272.81M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$2.69M derived: sum of 2 quarters · filed 2012-11-06 | -$4.17M 10-Q · filed 2012-11-06 | $41.57M derived: sum of 4 quarters · filed 2012-11-06 | $273.80M 10-Q/A · filed 2012-03-30 | |||||
| 2011-06-30 | -$679.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | -$2.16M 10-Q · filed 2012-07-27 | $43.57M derived: sum of 3 quarters · filed 2012-07-27 | $41.92M derived: sum of 4 quarters · filed 2012-07-27 | $275.81M 10-Q/A · filed 2012-03-30 | |||||
| 2011-03-31 | -$1.48M 10-Q · filed 2012-05-08 | $44.25M derived: sum of 2 quarters · filed 2012-05-08 | $42.60M derived: sum of 3 quarters · filed 2012-05-08 | |||||||
| 2010-12-31 | $45.73M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $44.08M derived: sum of 2 quarters · filed 2012-03-30 | $61.67M 10-K · filed 2012-03-30 | |||||||
| 2010-09-30 | -$1.65M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-30 | $15.94M 10-Q/A · filed 2012-03-30 | ||||||||
| 2010-06-30 | $17.59M 10-Q/A · filed 2012-03-30 | |||||||||
| 2009-12-31 | $26.43M 10-K · filed 2012-03-30 |